The stock of ESSA Pharma Inc (TSE:EPI) is a huge mover today! About 12,000 shares traded hands or 67.18% up from the average. ESSA Pharma Inc (TSE:EPI) has declined 12.99% since February 10, 2016 and is downtrending. It has underperformed by 29.48% the S&P500.
The move comes after 8 months negative chart setup for the $91.87 million company. It was reported on Sep, 13 by Barchart.com. We have $2.78 PT which if reached, will make TSE:EPI worth $11.02 million less.
ESSA Pharma, Inc. is a Canada-based clinical-stage pharmaceutical company. The company has a market cap of $91.87 million. The Firm is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). It currently has negative earnings. The Company’s segment is the development of small molecule drugs for prostate cancer.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.